These beneficial effects are complementary to the reported beneficial effects specifically noted with VEGF [84,92,93,94,95,96], NO-system [11,29,92,93,94,97,98,99], egr-1 gene [100], and carcinoma [22,95] models. The gene discussed is VEGFA; the disease is carcinoma.